These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11718429)

  • 1. COX-2 inhibitors: balancing the hope, the hype, and the concern.
    Mandell BF
    Cleve Clin J Med; 2001 Nov; 68(11):899. PubMed ID: 11718429
    [No Abstract]   [Full Text] [Related]  

  • 2. Cox-2 inhibitors and cardiovascular risk: point and counterpoint.
    Mandell BF
    Cleve Clin J Med; 2001 Nov; 68(11):957-60. PubMed ID: 11718436
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular events and COX-2 inhibitors.
    White WB; Whelton A
    JAMA; 2001 Dec; 286(22):2811-2. PubMed ID: 11735749
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular events and COX-2 inhibitors.
    Konstam MA; Demopoulos LA
    JAMA; 2001 Dec; 286(22):2809; author reply 2811-2. PubMed ID: 11735743
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular events and COX-2 inhibitors.
    Grant KD
    JAMA; 2001 Dec; 286(22):2809; author reply 2811-2. PubMed ID: 11735744
    [No Abstract]   [Full Text] [Related]  

  • 6. COX-2 inhibitors in the treatment of cardiovascular disease.
    Raynauld JP
    CMAJ; 2002 Oct; 167(7):739; author reply 739-40. PubMed ID: 12389825
    [No Abstract]   [Full Text] [Related]  

  • 7. COX-2 inhibitors in the treatment of cardiovascular disease.
    Peterson JC
    CMAJ; 2002 Oct; 167(7):738-9; author reply 739-40. PubMed ID: 12389824
    [No Abstract]   [Full Text] [Related]  

  • 8. [Gastrointestinal and cardiovascular side effects associated with COX-2 selective inhibitors].
    Lanas A
    Med Clin (Barc); 2002 Feb; 118(6):237-8. PubMed ID: 11864548
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular events and COX-2 inhibitors.
    Haldey EJ; Pappagallo M
    JAMA; 2001 Dec; 286(22):2809-10; author reply 2811-2. PubMed ID: 11735745
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cardiovascular ffects of COX-2 selective anti-inflammatory agents].
    Halinen MO
    Duodecim; 2001; 117(24):2570-1. PubMed ID: 12183817
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular events and COX-2 inhibitors.
    Singh G
    JAMA; 2001 Dec; 286(22):2810-1; author reply 2811-2. PubMed ID: 11735748
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclo-oxygenase-2 inhibitors and cardiovascular events.
    Warner TD; Mitchell JA; Vane JR
    Lancet; 2002 Nov; 360(9346):1700-1. PubMed ID: 12457830
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular events and COX-2 inhibitors.
    Burnakis TG
    JAMA; 2001 Dec; 286(22):2808; author reply 2811-2. PubMed ID: 11735741
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclooxygenase 2 inhibitors.
    Kelley KW; Ramsey LA
    Adv Nurse Pract; 2003 Mar; 11(3):22-4. PubMed ID: 12683165
    [No Abstract]   [Full Text] [Related]  

  • 15. [Selective inhibitors of cyclooxigenase-2 (Coxibs) and cardiovascular morbidity].
    Ruilope LM; Coca A
    Med Clin (Barc); 2002 Feb; 118(6):219-21. PubMed ID: 11864545
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclooxygenase-2 inhibition and cardiovascular events.
    Pitt B; Pepine C; Willerson JT
    Circulation; 2002 Jul; 106(2):167-9. PubMed ID: 12105151
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular events and COX-2 inhibitors.
    Minic M
    JAMA; 2001 Dec; 286(22):2810; author reply 2811-2. PubMed ID: 11735746
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.
    Baigent C; Patrono C
    Arthritis Rheum; 2003 Jan; 48(1):12-20. PubMed ID: 12528099
    [No Abstract]   [Full Text] [Related]  

  • 19. The coxibs, selective inhibitors of cyclooxygenase-2.
    Rich SA
    N Engl J Med; 2001 Dec; 345(23):1709. PubMed ID: 11759657
    [No Abstract]   [Full Text] [Related]  

  • 20. Cox-2 inhibitors and cardiovascular risk: we defend our data and suggest caution.
    Mukherjee D; Nissen SE; Topol EJ
    Cleve Clin J Med; 2001 Nov; 68(11):963-4. PubMed ID: 11718438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.